Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000899243-21-010806

Options or other derivatives

  • CHIEF EXECUTIVE OFFICER acquired 148,870 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 2021-03-05 Grant or award · Employee Stock Option (Right to Buy) +97,155 97,155 D
TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 2021-03-05 Grant or award · Restricted Stock Units +51,715 51,715 D
Loading xslF345X03/doc4.xml…